Lunsekimig

6 trials

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

0 Recruiting

4 Completed trials

1 Sponsors

14 Countries

Phase II/III

Phase II

Phase II/III: 2 Phase II: 4

Indications tested

Chronic rhinosinusitis with nasal polyps 2 Chronic obstructive pulmonary disease 2 Asthma 1 Dermatitis atopic 1

Sponsors using this IMP

Sanofi-Aventis Recherche & Developpement 6

All trials

6 total

Efficacy, safety, and tolerability study of lunsekimig compared with placebo in adult participants with inadequately controlled chronic obst… Pending

2024-518016-39-00 Phase II/III 3 countries Sanofi-Aventis Recherche & Developpement
Efficacy, safety, and tolerability study of lunsekimig compared with placebo in adult participants with inadequately controlled chronic obst… Pending

2024-518213-25-00 Phase II/III 2 countries Sanofi-Aventis Recherche & Developpement
Long-term safety and efficacy evaluation of lunsekimig in adult participants with chronic rhinosinusitis with nasal polyps (CRSwNP) who comp… Ended

2024-515912-27-00 Phase II 3 countries Sanofi-Aventis Recherche & Developpement
Study of lunsekimig (SAR443765) compared with placebo in adults with high-risk asthma Ended

2024-513959-33-00 Phase II 10 countries Sanofi-Aventis Recherche & Developpement
A study to investigate the efficacy and safety of subcutaneous lunsekimig (SAR443765) compared with placebo in adult participants with moder… Ended

2024-511549-20-00 Phase II 2 countries Sanofi-Aventis Recherche & Developpement
A proof-of-concept study of lunsekimig compared with placebo in adults with chronic rhinosinusitis with nasal polyps Ended

2024-511261-11-00 Phase II 3 countries Sanofi-Aventis Recherche & Developpement

Showing 1–6 of 6 trials

← All drugs A–Z